The U.S. International Trade Commission (“ITC”) has requested additional briefing from the parties due to the information that Acambis by the end of 2006 was notified by the U.S. Department of Health & Human Services (“HHS”) that they are out of competitive range for an award as part of the Modified Vaccinia Ankara (“MVA”) smallpox vaccine tender process.
Bavarian Nordic, U.S. International Trade Commission requests additional briefing relating to remedy
| Source: Bavarian Nordic A/S
Attachments
